admin

0 Comments
In the midst of a challenging global landscape characterized by the ongoing Covid-19 pandemic, Swiss pharmaceutical giant Roche has managed to navigate through uncertainty and report a modest uptick in first-quarter sales. Despite facing waning demand for its Covid-19 products, the company has shown resilience in the face of adversity. Roche reported a 2% increase
0 Comments
Boeing’s upcoming quarterly report is expected to shed light on the repercussions of a door plug loss incident in January involving a 737 Max 9 plane. This incident not only led to another safety crisis for the company but also brought additional federal scrutiny and a slowdown in production. As a result, analysts are predicting
0 Comments
PepsiCo recently released its quarterly earnings report, surprising analysts with better-than-expected results despite facing challenges in the U.S. market. The company reported a net income of $2.04 billion, or $1.48 per share, beating Wall Street expectations. However, PepsiCo’s stock saw a decline of over 2% in morning trading, signaling investor concerns regarding the future outlook
0 Comments
Novartis, the Swiss drugmaker, saw a significant increase in its stock price by as much as 4.8% following the release of its first-quarter results. The company demonstrated better-than-expected performance, leading to a boost in investor confidence. With net sales rising by 11% and core operating income increasing by 22% in the first three months of